Signal transduction in smooth muscle - Selected contribution: NO released to flow reduces myogenic tone of skeletal muscle arterioles by decreasing smooth muscle Ca2+ sensitivity
Z. Ungvari et A. Koller, Signal transduction in smooth muscle - Selected contribution: NO released to flow reduces myogenic tone of skeletal muscle arterioles by decreasing smooth muscle Ca2+ sensitivity, J APP PHYSL, 91(1), 2001, pp. 522-527
To clarify the contribution of intracellular Ca2+ concentration ([Ca2+](i))
dependent and -independent signaling mechanisms in arteriolar smooth muscl
e (aSM) to modulation of arteriolar myogenic tone by nitric oxide (NO), rel
eased in response to increases in intraluminal flow from the endothelium, c
hanges in aSM [Ca2+](i) and diameter of isolated rat gracilis muscle arteri
oles (pretreated with indomethacin) were studied by fluorescent videomicros
copy. At an intraluminal pressure of 80 mmHg, [Ca2+](i) significantly incre
ased and myogenic tone developed in response to elevations of extracellular
Ca2+ concentration. The Ca2+ channel inhibitor nimodipine substantially de
creased [Ca2+](i) and completely inhibited myogenic tone. Dilations to intr
aluminal flow (that were inhibited by N-omega-nitro-L-arginine methyl ester
) or dilations to the NO donor S-nitroso-N-acetyl-DL-penicillamine (that we
re inhibited by the guanylate cyclase inhibitor 1H-[1,2,4] oxadiazolo[4,3-a
]quinoxalin-1-one) were not accompanied by substantial decreases in aSM [Ca
2+](i). 8-Bromoguanosine cGMP and the cGMP-specific phosphodiesterase inhib
itor zaprinast significantly dilated arterioles yet elicited only minimal d
ecreases in [Ca2+](i). Thus flow-induced endothelial release of NO elicits
relaxation of arteriolar smooth muscle by a cGMP-dependent decrease of the
Ca2+ sensitivity of the contractile apparatus without substantial changes i
n the pressure-induced level of [Ca2+](i).